Catalent to manufacture Moderna's personalized cancer vaccine for Ph I/II studies

By Melissa Fassbender contact

- Last updated on GMT

Clinical study of Moderna's mRNA personalized cancer vaccine is expected to begin in 2017. (Image: Catalent)
Clinical study of Moderna's mRNA personalized cancer vaccine is expected to begin in 2017. (Image: Catalent)

Related tags: Vaccine

Catalent has entered into an agreement with Moderna Therapeutics to support the company’s proprietary production process.

Mike Riley, VP and General Manager of Catalent​ Biologics confirmed that the company will be providing cGMP manufacturing of Moderna’s mRNA personalized cancer vaccine for phase I/II clinical studies.

According to the company, clinical study of the vaccine is expected to begin in 2017.

Under the agreement, Catalent will be providing dedicated production capability to accommodate Moderna’s proprietary production process, and support fast turnaround of clinical material​,” Riley told us.

Work will take place at Catalent’s Madison, WI-based facility, which was opened in 2013 to support both flexible cGMP and non-GMP production.

The site features integrated process development and analytical capabilities, including the support of method development, in-process, release and stability testing​,” said Riley.

Additionally, Catalent recently announced an expansion to the facility, which Riley said will create increased capacity for later phase clinical and commercial production.

Related topics: Bio-Outsourcing

Related news

Show more

Related products

show more

Liposomal and Nanoparticle Technology

Liposomal and Nanoparticle Technology

Pfizer CentreOne | 18-Nov-2022 | Technical / White Paper

Medical science is continuously searching for better ways to administer drugs into the body and to maximize the therapeutic effectiveness of the drugs...

GMP manufacturing of buffers and liquid blends

GMP manufacturing of buffers and liquid blends

Actylis – The Partner of Choice | 16-Nov-2022 | Technical / White Paper

Actylis manufactures buffers, process solutions, cleaning solutions, Water for Injection (WFI) for further processing, and custom liquid blends in compliance...

Related suppliers

Follow us

Products

View more

Webinars